Abu Dhabi, United Arab Emirates/ Athens, Greece – March 17, 2026 RTsafe announces that RTsafeGulf Limited, its regional entity based in Masdar City Free Zone, Abu Dhabi, has received an official licence from the Federal Authority for Nuclear Regulation (FANR) to provide specialized medical physics and radiation safety services in radiotherapy in the United Arab […]

Athens, Greece, February 19, 2026 RTsafe is proud to announce that its core innovation, the PseudoPatient®, has received official Medical Device Marketing Authorization (MDMA-2-2026-0352) from the Saudi Food & Drug Authority (SFDA). This important regulatory milestone enables RTsafe to market and distribute PseudoPatient across the Kingdom of Saudi Arabia and represents a significant step forward […]

Athens, Greece / Brisbane, Australia – December 15, 2025  RTsafe, a leading medical technology company specialising in quality assurance (QA) solutions for radiation therapy, and Icon Group (Icon), a leading integrated cancer care provider with a global reach across Australia, New Zealand, ASEAN, Mainland China and the United Kingdom, today announced the purchase of two RTsafe PRIME phantoms. These are the first PRIME phantoms to […]